INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• The Case For Cognitive Assessments In Phase 1 Clinical Trials

  Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.

• Taking eCOA Technology Deployment Off The Critical Path

  Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.

• Simplify Clinical Trials With Signant SmartSignals® Unified Platform

  Signant SmartSignals® Unified Platform streamlines clinical trials by integrating eConsent, data collection, remote consultations, and randomization, simplifying workflows for patients and site staff.

• The Write Side Of AI: Augmenting Capabilities, Not Replacing Them

  AI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.

• From Frustration To Organization: An SSO Platform For Trial Sites

  5/2/2025

  To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

• Sikich Success For Life Sciences

  4/3/2025

  Explore an innovative solution for early-stage Life Sciences Organizations featuring dimensional charts of accounts, program and project management, multi-subsidiary support, and mass securities.

• Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch

  4/22/2024

  The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

• The Connected Patient In Clinical Trials

  12/23/2025

  Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.

• Diversity In Clinical Trials: How Companies Are Tackling The Issue

  1/24/2024

  Experts from Genentech, Moderna, and Patientory share how collaborative approaches involving technology and multiple resources can improve health outcomes and increase diversity in clinical trials.